Cargando…
The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion
BACKGROUND: In-transit metastasis is considered a locoregional disease in cutaneous melanoma (CM) patients. Isolated limb perfusion (ILP) is among the treatment options in selected cases. The aim of this study was to determine the success of pre- and post-perfusion mSIS values in predicting the pote...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594072/ https://www.ncbi.nlm.nih.gov/pubmed/34781987 http://dx.doi.org/10.1186/s12957-021-02437-6 |
_version_ | 1784599891568230400 |
---|---|
author | Morkavuk, Şevket Barış Çulcu, Serdar Esen, Ebru Ünal, Ali Ekrem |
author_facet | Morkavuk, Şevket Barış Çulcu, Serdar Esen, Ebru Ünal, Ali Ekrem |
author_sort | Morkavuk, Şevket Barış |
collection | PubMed |
description | BACKGROUND: In-transit metastasis is considered a locoregional disease in cutaneous melanoma (CM) patients. Isolated limb perfusion (ILP) is among the treatment options in selected cases. The aim of this study was to determine the success of pre- and post-perfusion mSIS values in predicting the potential complications and the prognosis of the disease by investigating the early and long-term results of mSIS values calculated before and after ILP in CM cases with in-transit metastases. MATERIALS AND METHODS: Patients who underwent ILP within the period from 2014 to 2020 in our department were retrospectively scanned. A total of 20 patients were found to undergo ILP. The scores obtained from modified inflammation score (mSIS) were formulated according to albumin (Alb) and lymphocyte to monocyte ratio (LMR) scores. RESULTS: The mean follow-up time was 20.47 months. Complications requiring surgical intervention developed in three patients. According to the Wieberdink local toxicity classification, the majority (70%) of the patients were found to be grade II. Based on pre-perfusion mSIS values, 8 patients were classified as mSIS 0 while six patients were classified as mSIS 1 and 2. Based on post-perfusion mSIS values, 14 patients and one patient were classified as mSIS 2 (70%) and mSIS 0, respectively. Accordingly, univariate analysis showed that mSIS 1 and mSIS 2 were negative prognostic factors for mean survival in the pre-perfusion period (HR 0.162, 95% CI 0.036–0.729; p = 0.018 and HR: 0.223, 95% CI 0.049–1.019; p = 0.053) whereas albumin (Alb) and lymphocyte to monocyte ratio (LMR) were not independent prognostic factors for mean survival. CONCLUSION: The mSIS values calculated in the pre-perfusion period can give an opinion about the OS of the patients whereas post-perfusion mSIS values may predict potential surgical complications and local toxicities. |
format | Online Article Text |
id | pubmed-8594072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85940722021-11-16 The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion Morkavuk, Şevket Barış Çulcu, Serdar Esen, Ebru Ünal, Ali Ekrem World J Surg Oncol Research BACKGROUND: In-transit metastasis is considered a locoregional disease in cutaneous melanoma (CM) patients. Isolated limb perfusion (ILP) is among the treatment options in selected cases. The aim of this study was to determine the success of pre- and post-perfusion mSIS values in predicting the potential complications and the prognosis of the disease by investigating the early and long-term results of mSIS values calculated before and after ILP in CM cases with in-transit metastases. MATERIALS AND METHODS: Patients who underwent ILP within the period from 2014 to 2020 in our department were retrospectively scanned. A total of 20 patients were found to undergo ILP. The scores obtained from modified inflammation score (mSIS) were formulated according to albumin (Alb) and lymphocyte to monocyte ratio (LMR) scores. RESULTS: The mean follow-up time was 20.47 months. Complications requiring surgical intervention developed in three patients. According to the Wieberdink local toxicity classification, the majority (70%) of the patients were found to be grade II. Based on pre-perfusion mSIS values, 8 patients were classified as mSIS 0 while six patients were classified as mSIS 1 and 2. Based on post-perfusion mSIS values, 14 patients and one patient were classified as mSIS 2 (70%) and mSIS 0, respectively. Accordingly, univariate analysis showed that mSIS 1 and mSIS 2 were negative prognostic factors for mean survival in the pre-perfusion period (HR 0.162, 95% CI 0.036–0.729; p = 0.018 and HR: 0.223, 95% CI 0.049–1.019; p = 0.053) whereas albumin (Alb) and lymphocyte to monocyte ratio (LMR) were not independent prognostic factors for mean survival. CONCLUSION: The mSIS values calculated in the pre-perfusion period can give an opinion about the OS of the patients whereas post-perfusion mSIS values may predict potential surgical complications and local toxicities. BioMed Central 2021-11-16 /pmc/articles/PMC8594072/ /pubmed/34781987 http://dx.doi.org/10.1186/s12957-021-02437-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Morkavuk, Şevket Barış Çulcu, Serdar Esen, Ebru Ünal, Ali Ekrem The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion |
title | The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion |
title_full | The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion |
title_fullStr | The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion |
title_full_unstemmed | The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion |
title_short | The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion |
title_sort | diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594072/ https://www.ncbi.nlm.nih.gov/pubmed/34781987 http://dx.doi.org/10.1186/s12957-021-02437-6 |
work_keys_str_mv | AT morkavuksevketbarıs thediagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion AT culcuserdar thediagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion AT esenebru thediagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion AT unalaliekrem thediagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion AT morkavuksevketbarıs diagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion AT culcuserdar diagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion AT esenebru diagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion AT unalaliekrem diagnosticvalueofmodifiedsystemicınflammationscoreinpredictingpostoperativeoutcomesofcutaneousmelanomapatientswhounderwentısolatedlimbperfusion |